Literature DB >> 28422568

cGAS-STING-TBK1-IRF3/7 induced interferon-β contributes to the clearing of non tuberculous mycobacterial infection in mice.

Nanthapon Ruangkiattikul1, Andreas Nerlich1, Ketema Abdissa1,2, Stefan Lienenklaus2, Abdulhadi Suwandi2, Nina Janze1, Kristin Laarmann1, Julia Spanier3, Ulrich Kalinke3, Siegfried Weiss2,4, Ralph Goethe1.   

Abstract

Type I interferons (IFN-I), such as IFN-α and IFN-β are important messengers in the host response against bacterial infections. Knowledge about the role of IFN-I in infections by nontuberculous mycobacteria (NTM) is limited. Here we show that macrophages infected with pathogens of the Mycobacterium avium complex produced significantly lower amounts of IFN-β than macrophages infected with the opportunistic pathogen M. smegmatis. To dissect the molecular mechanisms of this phenomenon, we focused on the obligate pathogen Mycobacterium avium ssp paratuberculosis (MAP) and the opportunistic M. smegmatis. Viability of both bacteria was required for induction of IFN-β in macrophages. Both bacteria induced IFN-β via the cGAS-STING-TBK1-IRF3/7-pathway of IFN-β activation. Stronger phosphorylation of TBK1 and higher amounts of extracellular bacterial DNA in the macrophage cytosol were found in M. smegmatis infected macrophages than in MAP infected macrophages. After intraperitoneal infection of mice, a strong Ifnb induction by M. smegmatis correlated with clearance of the bacteria. In contrast, MAP only induced weak Ifnb expression which correlated with bacterial persistence and increased number of granulomas in the liver. In mice lacking the type I interferon receptor we observed improved survival of M. smegmatis while survival of MAP was similar to that in wildtype mice. On the other hand, treatment of MAP infected wildtype mice with the IFN-I inducer poly(I:C) or recombinant IFN-β impaired the survival of MAP. This indicates an essential role of IFN-I in clearing infections by MAP and M. smegmatis. The expression level of IFN-I is decisive for transient versus persistent NTM infection.

Entities:  

Keywords:  STING; Type I interferon; cGAS; extracellular DNA; mycobacterium paratuberculosis; mycobacterium smegmatis; non tuberculous mycobacteria

Mesh:

Substances:

Year:  2017        PMID: 28422568      PMCID: PMC5711412          DOI: 10.1080/21505594.2017.1321191

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  52 in total

1.  Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  John Kuchtey; Scott A Fulton; Scott M Reba; Clifford V Harding; W Henry Boom
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  Cutting edge: Mycobacterium tuberculosis but not nonvirulent mycobacteria inhibits IFN-β and AIM2 inflammasome-dependent IL-1β production via its ESX-1 secretion system.

Authors:  Swati Shah; Amro Bohsali; Sarah E Ahlbrand; Lalitha Srinivasan; Vijay A K Rathinam; Stefanie N Vogel; Katherine A Fitzgerald; Fayyaz S Sutterwala; Volker Briken
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

3.  The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9.

Authors:  Koichi Tabeta; Kasper Hoebe; Edith M Janssen; Xin Du; Philippe Georgel; Karine Crozat; Suzanne Mudd; Navjiwan Mann; Sosathya Sovath; Jason Goode; Louis Shamel; Anat A Herskovits; Daniel A Portnoy; Michael Cooke; Lisa M Tarantino; Tim Wiltshire; Benjamin E Steinberg; Sergio Grinstein; Bruce Beutler
Journal:  Nat Immunol       Date:  2006-01-15       Impact factor: 25.606

4.  Mycobacterium tuberculosis Differentially Activates cGAS- and Inflammasome-Dependent Intracellular Immune Responses through ESX-1.

Authors:  Ruth Wassermann; Muhammet F Gulen; Claudia Sala; Sonia Garcia Perin; Ye Lou; Jan Rybniker; Jonathan L Schmid-Burgk; Tobias Schmidt; Veit Hornung; Stewart T Cole; Andrea Ablasser
Journal:  Cell Host Microbe       Date:  2015-06-02       Impact factor: 21.023

5.  The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis.

Authors:  Sarah A Stanley; James E Johndrow; Paolo Manzanillo; Jeffery S Cox
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

6.  A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.

Authors:  Kari A Sweeney; Dee N Dao; Michael F Goldberg; Tsungda Hsu; Manjunatha M Venkataswamy; Marcela Henao-Tamayo; Diane Ordway; Rani S Sellers; Paras Jain; Bing Chen; Mei Chen; John Kim; Regy Lukose; John Chan; Ian M Orme; Steven A Porcelli; William R Jacobs
Journal:  Nat Med       Date:  2011-09-04       Impact factor: 53.440

7.  Essential role of IRF-3 in lipopolysaccharide-induced interferon-beta gene expression and endotoxin shock.

Authors:  Shinya Sakaguchi; Hideo Negishi; Masataka Asagiri; Chigusa Nakajima; Tatsuaki Mizutani; Akinori Takaoka; Kenya Honda; Tadatsugu Taniguchi
Journal:  Biochem Biophys Res Commun       Date:  2003-07-11       Impact factor: 3.575

8.  The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-β during Chlamydia trachomatis infection.

Authors:  Yugen Zhang; Laxmi Yeruva; Anthony Marinov; Daniel Prantner; Priscilla B Wyrick; Vladimir Lupashin; Uma M Nagarajan
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

9.  Infergen Stimulated Macrophages Restrict Mycobacterium tuberculosis Growth by Autophagy and Release of Nitric Oxide.

Authors:  Susanta Pahari; Nargis Khan; Mohammad Aqdas; Shikha Negi; Jagdeep Kaur; Javed N Agrewala
Journal:  Sci Rep       Date:  2016-12-21       Impact factor: 4.379

10.  The Mycobacterium avium ssp. paratuberculosis specific mptD gene is required for maintenance of the metabolic homeostasis necessary for full virulence in mouse infections.

Authors:  Thorsten Meißner; Elke Eckelt; Tina Basler; Jochen Meens; Julia Heinzmann; Abdulhadi Suwandi; Walter M R Oelemann; Sandra Trenkamp; Otto Holst; Siegfried Weiss; Boyke Bunk; Cathrin Spröer; Gerald-F Gerlach; Ralph Goethe
Journal:  Front Cell Infect Microbiol       Date:  2014-08-14       Impact factor: 5.293

View more
  20 in total

1.  Ipr1 Regulation by Cyclic GMP-AMP Synthase/Interferon Regulatory Factor 3 and Modulation of Irgm1 Expression via p53.

Authors:  Fayang Liu; Hongni Xue; Jie Ke; Yongyan Wu; Kezhen Yao; Shuxin Liang; Aihua Xu; Yong Zhang
Journal:  Mol Cell Biol       Date:  2020-03-30       Impact factor: 4.272

2.  Interferon-β controls non-tuberculous mycobacterial infection in mice.

Authors:  Mohd-Nor Norazmi
Journal:  Virulence       Date:  2017-06-12       Impact factor: 5.882

3.  Mycobacterium tuberculosis Inhibits Autocrine Type I IFN Signaling to Increase Intracellular Survival.

Authors:  Dallas A Banks; Sarah E Ahlbrand; V Keith Hughitt; Swati Shah; Katrin D Mayer-Barber; Stefanie N Vogel; Najib M El-Sayed; Volker Briken
Journal:  J Immunol       Date:  2019-03-04       Impact factor: 5.422

Review 4.  Cytosolic detection of phagosomal bacteria-Mechanisms underlying PAMP exodus from the phagosome into the cytosol.

Authors:  Stephanie A Ragland; Jonathan C Kagan
Journal:  Mol Microbiol       Date:  2021-11-22       Impact factor: 3.501

5.  The intracellular DNA sensors cGAS and IFI16 do not mediate effective antiviral immune responses to HSV-1 in human microglial cells.

Authors:  Austin M Jeffries; Andrew W Truman; Ian Marriott
Journal:  J Neurovirol       Date:  2020-06-02       Impact factor: 2.643

Review 6.  Macrophage-microbe interaction: lessons learned from the pathogen Mycobacterium tuberculosis.

Authors:  Somdeb BoseDasgupta; Jean Pieters
Journal:  Semin Immunopathol       Date:  2018-10-10       Impact factor: 9.623

Review 7.  Impact of Type I Interferons on Susceptibility to Bacterial Pathogens.

Authors:  Adeline Peignier; Dane Parker
Journal:  Trends Microbiol       Date:  2021-02-02       Impact factor: 18.230

Review 8.  Type I Interferons in the Pathogenesis of Tuberculosis: Molecular Drivers and Immunological Consequences.

Authors:  Meg L Donovan; Thomas E Schultz; Taylor J Duke; Antje Blumenthal
Journal:  Front Immunol       Date:  2017-11-27       Impact factor: 7.561

Review 9.  Type I interferons in tuberculosis: Foe and occasionally friend.

Authors:  Lúcia Moreira-Teixeira; Katrin Mayer-Barber; Alan Sher; Anne O'Garra
Journal:  J Exp Med       Date:  2018-04-17       Impact factor: 17.579

10.  Immunodominant Mycobacterium tuberculosis Protein Rv1507A Elicits Th1 Response and Modulates Host Macrophage Effector Functions.

Authors:  Simran Kaur Arora; Anwar Alam; Nilofer Naqvi; Javeed Ahmad; Javaid Ahmad Sheikh; Syed Asad Rahman; Seyed Ehtesham Hasnain; Nasreen Zafar Ehtesham
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.